Zenabis worth more than CanniMed was back in 2018Aurora Cannabis Inc. says its $1.1-billion bid to acquire CanniMed Therapeutics Inc. has been successful, back in March 2018.
Old news but the point I want to make is that if Zenabis can some favourable valuation such as Saskatoon-based CanniMed was afforded, even just a fraction of the valuation, Zenabis would be $0.2-billion. After this Offering, ZENA shares outstanding will be 714 million, so that's 28 cents a share for ZENA. This is a conservative analysis.